Literature DB >> 35608583

Dapagliflozin Safe and Effective for Heart Failure With Frailty.

Anita Slomski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35608583     DOI： 10.1001/jama.2022.8171

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  1 in total

1.  Association between SGLT2 Inhibitors and Cardiac Rehabilitation Outcomes in Patients with Cardiovascular Disease and Type 2 Diabetes Mellitus.

Authors:  Ayuko Kashima; Kentaro Kamiya; Nobuaki Hamazaki; Kensuke Ueno; Kohei Nozaki; Takafumi Ichikawa; Masashi Yamashita; Shota Uchida; Takumi Noda; Kazuki Hotta; Emi Maekawa; Minako Yamaoka-Tojo; Atsuhiko Matsunaga; Junya Ako
Journal:  J Clin Med       Date:  2022-10-09       Impact factor: 4.964
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.